{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T00:50:12Z","timestamp":1793321412724,"version":"4.5.0"},"reference-count":30,"publisher":"American Society of Hematology","issue":"1","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,12,8]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>A consumptive coagulopathy describes a situation where there is a loss of hemostatic factors, which leads to an increased risk of bleeding. Some recent studies have used the term interchangeably with disseminated intravascular coagulation (DIC), but we have reverted to the older definition, which covers a broader range of issues where there is loss of hemostatic factors due to multiple causes, which includes systemic activation of coagulation as seen in DIC. Therefore, the term consumptive coagulopathy covers conditions from the hemostatic effects of major hemorrhage to the use of extracorporeal circuits to true DIC. We review the current understanding of the pathophysiology, diagnosis, and management of common consumptive coagulopathy in critical care patients, focusing on recent advances and controversies. Particular emphasis is given to DIC because it is a common and often life-threatening condition in critical care patients and is characterized by the simultaneous occurrence of widespread microvascular thrombosis and bleeding. Second, we focus on the effect of modern medical technology, such as extracorporeal membrane oxygenation, on hemostasis.<\/jats:p>","DOI":"10.1182\/hematology.2023000502","type":"journal-article","created":{"date-parts":[[2023,12,8]],"date-time":"2023-12-08T15:15:15Z","timestamp":1702048515000},"page":"754-760","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":16,"title":["Consumptive coagulopathy in the ICU"],"prefix":"10.1182","volume":"2023","author":[{"given":"Andrew","family":"Retter","sequence":"first","affiliation":[{"name":"1 Guy\u2018s and St. Thomas\u2019 NHS Foundation Trust, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beverley J.","family":"Hunt","sequence":"additional","affiliation":[{"name":"2 Kings Healthcare Partners and Thrombosis & Haemophilia Centre, GSTT, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2023,12,8]]},"reference":[{"key":"2023120815090411400_hem2023000502C1","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1056\/NEJMra1208626","article-title":"Bleeding and coagulopathies in critical care","volume":"370","author":"Hunt","year":"2014","journal-title":"N Engl J Med"},{"issue":"8","key":"2023120815090411400_hem2023000502C2","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1038\/nm.2184","article-title":"Reciprocal coupling of coagulation and innate immunity via neutrophil serine proteases","volume":"16","author":"Massberg","year":"2010","journal-title":"Nat Med"},{"issue":"11","key":"2023120815090411400_hem2023000502C3","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1111\/jth.14578","article-title":"Diagnosis and management of sepsis-induced coagulopathy and disseminated intravascular coagulation","volume":"17","author":"Iba","year":"2019","journal-title":"J Thromb Haemost"},{"issue":"1","key":"2023120815090411400_hem2023000502C4","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s40560-023-00672-5","article-title":"The pathophysiology, diagnosis, and management of sepsis-associated disseminated intravascular coagulation","volume":"11","author":"Iba","year":"2023","journal-title":"J Intensive Care"},{"issue":"36","key":"2023120815090411400_hem2023000502C5","doi-asserted-by":"crossref","first-page":"15880","DOI":"10.1073\/pnas.1005743107","article-title":"Extracellular DNA traps promote thrombosis","volume":"107","author":"Fuchs","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5663","key":"2023120815090411400_hem2023000502C6","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1126\/science.1092385","article-title":"Neutrophil extracellular traps kill bacteria","volume":"303","author":"Brinkmann","year":"2004","journal-title":"Science"},{"issue":"18","key":"2023120815090411400_hem2023000502C7","doi-asserted-by":"crossref","first-page":"2768","DOI":"10.1182\/blood-2013-10-463646","article-title":"Thrombosis: tangled up in NETs","volume":"123","author":"Martinod","year":"2014","journal-title":"Blood"},{"issue":"3","key":"2023120815090411400_hem2023000502C8","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.thromres.2011.10.013","article-title":"Sepsis, thrombosis and organ dysfunction","volume":"129","author":"Semeraro","year":"2012","journal-title":"Thromb Res"},{"issue":"7","key":"2023120815090411400_hem2023000502C9","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1164\/rccm.201811-2111OC","article-title":"A novel assay for neutrophil extracellular trap formation independently predicts disseminated intravascular coagulation and mortality in critically ill patients","volume":"200","author":"Abrams","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"2023120815090411400_hem2023000502C10","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1189\/jlb.3A0415-161R","article-title":"Mediators and molecular pathways involved in the regulation of neutrophil extracellular trap formation mediated by activated platelets","volume":"99","author":"Carestia","year":"2016","journal-title":"J Leukoc Biol"},{"issue":"21","key":"2023120815090411400_hem2023000502C11","doi-asserted-by":"crossref","first-page":"8674","DOI":"10.1073\/pnas.1301059110","article-title":"Neutrophil histone modification by peptidylarginine deiminase 4 is critical for deep vein thrombosis in mice","volume":"110","author":"Martinod","year":"2013","journal-title":"Proc Natl Acad Sci USA"},{"issue":"7","key":"2023120815090411400_hem2023000502C12","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1182\/blood-2013-07-514984","article-title":"Nonanticoagulant heparin prevents histone-mediated cytotoxicity in vitro and improves survival in sepsis","volume":"123","author":"Wildhagen","year":"2014","journal-title":"Blood"},{"issue":"1","key":"2023120815090411400_hem2023000502C13","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/2052-0492-2-15","article-title":"Diagnosis and treatment of disseminated intravascular coagulation (DIC) according to four DIC guidelines","volume":"2","author":"Wada","year":"2014","journal-title":"J Intensive Care"},{"issue":"22","key":"2023120815090411400_hem2023000502C14","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1056\/NEJMoa1202290","article-title":"Drotrecogin alfa (activated) in adults with septic shock","volume":"366","author":"Ranieri","year":"2012","journal-title":"N Engl J Med"},{"issue":"8","key":"2023120815090411400_hem2023000502C15","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1182\/blood-2017-10-804096","article-title":"How I treat disseminated intravascular coagulation","volume":"131","author":"Levi","year":"2018","journal-title":"Blood"},{"issue":"2","key":"2023120815090411400_hem2023000502C16","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.jhep.2010.01.042","article-title":"Hemostasis and thrombosis in patients with liver disease: the ups and downs","volume":"53","author":"Lisman","year":"2010","journal-title":"J Hepatol"},{"issue":"2","key":"2023120815090411400_hem2023000502C17","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1002\/hep.28628","article-title":"Coagulation parameters and major bleeding in critically ill patients with cirrhosis","volume":"64","author":"Drolz","year":"2016","journal-title":"Hepatology"},{"issue":"2","key":"2023120815090411400_hem2023000502C18","doi-asserted-by":"crossref","first-page":"103094","DOI":"10.1016\/j.transci.2021.103094","article-title":"Symmetrical peripheral gangrene in critical illness","volume":"60","author":"Warkentin","year":"2021","journal-title":"Transfus Apher Sci"},{"issue":"8","key":"2023120815090411400_hem2023000502C19","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1007\/s00134-015-3934-7","article-title":"Epidemiology of acute kidney injury in critically ill patients: the multinational AKI-EPI study","volume":"41","author":"Hoste","year":"2015","journal-title":"Intensive Care Med"},{"issue":"9987","key":"2023120815090411400_hem2023000502C20","doi-asserted-by":"crossref","first-page":"2616","DOI":"10.1016\/S0140-6736(15)60126-X","article-title":"International Society of Nephrology's 0by25 initiative for acute kidney injury (zero preventable deaths by 2025): a human rights case for nephrology","volume":"385","author":"Mehta","year":"2015","journal-title":"Lancet"},{"issue":"2","key":"2023120815090411400_hem2023000502C21","doi-asserted-by":"crossref","first-page":"R65","DOI":"10.1186\/cc12598","article-title":"The epidemiology of septic shock in French intensive care units: the prospective multicenter cohort EPISS study","volume":"17","author":"Quenot","year":"2013","journal-title":"Crit Care"},{"issue":"4","key":"2023120815090411400_hem2023000502C22","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1111\/jth.15653","article-title":"Evaluation of novel coagulation and platelet function assays in patients with chronic kidney disease","volume":"20","author":"Abdelmaguid","year":"2022","journal-title":"J Thromb Haemost"},{"issue":"8","key":"2023120815090411400_hem2023000502C23","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/j.healun.2018.03.013","article-title":"Acquired von Willebrand syndrome and impaired platelet function during venovenous extracorporeal membrane oxygenation: rapid onset and fast recovery","volume":"37","author":"Kalbhenn","year":"2018","journal-title":"J Heart Lung Transplant"},{"issue":"14","key":"2023120815090411400_hem2023000502C24","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1161\/CIRCULATIONAHA.112.098194","article-title":"A prospective, randomized clinical trial of hemodynamic support with Impella 2.5 versus intra-aortic balloon pump in patients undergoing high-risk percutaneous coronary intervention: the PROTECT II Study","volume":"126","author":"O'Neill","year":"2012","journal-title":"Circulation"},{"key":"2023120815090411400_hem2023000502C25","first-page":"101007","article-title":"Use of Impella device in cardiogenic shock and its clinical outcomes: a systematic review and meta-analysis","volume":"40","author":"Panuccio","year":"2022","journal-title":"Int J Cardiol Heart Vasc"},{"issue":"1","key":"2023120815090411400_hem2023000502C26","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/s41572-021-00264-3","article-title":"Trauma-induced coagulopathy","volume":"7","author":"Moore","year":"2021","journal-title":"Nat Rev Dis Primers"},{"issue":"4","key":"2023120815090411400_hem2023000502C27","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1111\/bjh.18275","article-title":"Haematological management of major haemorrhage: a British Society for Haematology Guideline","volume":"198","author":"Stanworth","year":"2022","journal-title":"Br J Haematol"},{"issue":"12","key":"2023120815090411400_hem2023000502C28","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1007\/s00134-021-06531-x","article-title":"Transfusion strategies in bleeding critically ill adults: a clinical practice guideline from the European Society of Intensive Care Medicine","volume":"47","author":"Vlaar","year":"2021","journal-title":"Intensive Care Med"},{"issue":"6","key":"2023120815090411400_hem2023000502C29","doi-asserted-by":"crossref","first-page":"e210884","DOI":"10.1001\/jamasurg.2021.0884","article-title":"Association of intravenous tranexamic acid with thromboembolic events and mortality: a systematic review, meta-analysis, and meta-regression","volume":"156","author":"Taeuber","year":"2021","journal-title":"JAMA Surg"},{"issue":"16","key":"2023120815090411400_hem2023000502C30","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1001\/jama.2023.4080","article-title":"Efficacy and safety of early administration of 4-factor prothrombin complex concentrate in patients with trauma at risk of massive transfusion: the PROCOAG randomized clinical trial","volume":"329","author":"Bouzat","year":"2023","journal-title":"JAMA"}],"container-title":["Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/hematology\/article-pdf\/2023\/1\/754\/2175553\/754retter.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/hematology\/article-pdf\/2023\/1\/754\/2175553\/754retter.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,8]],"date-time":"2023-12-08T15:15:30Z","timestamp":1702048530000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/hematology\/article\/2023\/1\/754\/506487\/Consumptive-coagulopathy-in-the-ICU"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,8]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12,8]]},"published-print":{"date-parts":[[2023,12,8]]}},"URL":"https:\/\/doi.org\/10.1182\/hematology.2023000502","relation":{},"ISSN":["1520-4391","1520-4383"],"issn-type":[{"value":"1520-4391","type":"print"},{"value":"1520-4383","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,12,8]]},"published":{"date-parts":[[2023,12,8]]}}}